Laurion Capital Management »

Bridgebio Pharma shares owned by Laurion Capital Management

Quarter-by-quarter ownership of Bridgebio Pharma shares owned by Laurion Capital Management from 13F filings

Historical chart of Laurion Capital Management investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Laurion Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Laurion Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $16M 19M 0.84
2023-09-30 $15M 19M 0.76
2023-06-30 $12M 19M 0.62

More positions owned by Laurion Capital Management

Ishares Tr Iboxx Hi Yd Etf (HYG)
Meta Platforms Cl A Call Option (META)
Apple (AAPL)
Tesla Motors Call Option (TSLA)
Kenvue (KVUE)
Microsoft Corporation Call Option (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Alibaba Group Hldg Sponsored Ads Call Option (BABA)
Adobe Systems Incorporated Call Option (ADBE)
Alphabet Cap Stk Cl C Call Option (GOOG)
Bridgebio Pharma (BBIO)
NVIDIA Corporation Call Option (NVDA)
Bank of America Corporation (BAC)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Intel Corporation Call Option (INTC)

View all positions for Laurion Capital Management

Top funds holding Bridgebio Pharma

Braidwell
Ubs Global Asset Management Americas
D. E. Shaw & Co
Weiss Asset Management LP[1
Aristeia Capital
Context Capital Management
Laurion Capital Management
Point72 Asset Management
DeepCurrents Investment Group
Diameter Capital Partners
Wells Fargo & Company
Aequim Alternative Investments
Segantii Capital Management
Calamos Advisors
Lord, Abbett & Co

View all funds holding Bridgebio Pharma